Today: 20 May 2026
Why Resolute Holdings Management (RHLD) stock is jumping today — and what to watch next
13 January 2026
2 mins read

Why Resolute Holdings Management (RHLD) stock is jumping today — and what to watch next

New York, Jan 13, 2026, 13:48 EST — Regular session

  • RHLD shares rose after a filing revealed a long-term management-fee agreement linked to Husky’s operating performance
  • CompoSecure wrapped up its deal with Husky and set refinancing moves for this week
  • Traders eye CompoSecure’s refinancing set to close on Jan. 14 and its ticker switch on Jan. 23

Shares of Resolute Holdings Management, Inc. jumped roughly 11% to $234.70 in midday trading Tuesday in New York. The surge followed a regulatory filing detailing a fresh management deal linked to Husky Technologies’ earnings potential. That filing also revealed a planned auditor change for the next fiscal year.

This move is significant since Resolute’s model relies on recurring management fees, and the Husky contract brings in an additional revenue stream linked directly to operating results. Resolute calls itself a management company that handles operations and capital allocation at CompoSecure, marketing the setup as a “permanent capital platform” for acquisitions. Resolute Holdings

CompoSecure, the company behind the Resolute platform, finalized its merger with Husky on Jan. 12, according to a recent filing. The company also secured roughly $1.96 billion through a private investment in public equity (PIPE), selling new shares directly to investors at a fixed price. Shares of CompoSecure climbed around 3% on Tuesday.

CompoSecure announced the close, valuing the combined business at $7.4 billion. The company projects about $635 million in pro forma adjusted EBITDA for 2026, a profit measure excluding interest, taxes, and certain non-cash expenses. Executive Chairman Dave Cote and Chief Investment Officer Tom Knott said they were “thrilled” to finalize the deal and rebrand the entity as GPGI. They emphasized their ongoing commitment to shareholder value. The stock is set to begin trading under the new name and ticker “GPGI” on Jan. 23. GlobeNewswire

Husky moved quickly to quell rumors about its operations. CEO Bradley Selleck confirmed there are no immediate shifts in operations or customer service. He emphasized Husky’s commitment to its growth plan, with sustainability and innovation remaining “central” to its pipeline. Husky

Resolute’s new deal with Husky kicks off with a 10-year term and will roll over automatically into additional 10-year periods unless ended, according to the filing. Husky Holdings is set to pay a quarterly cash fee amounting to 2.5% of its adjusted EBITDA from the past 12 months — basically a share of operating profit — plus reimburse documented costs and expenses, excluding some specific exceptions.

The fee structure is straightforward, which generally appeals to the market. More importantly for investors, Resolute’s economics depend on how well the managed companies perform, not just on product sales from Resolute itself. This means that successful deal execution and effective operations can rapidly impact the stock price.

But there are risks in play. The filings highlight significant debt at Husky, which CompoSecure is refinancing. Management fees linked to adjusted EBITDA could drop sharply if margins falter or demand weakens. Plus, the agreements include termination clauses and possible fees that could work for or against the parties involved.

Resolute announced it’s switching auditors from Grant Thornton to Ernst & Young for the fiscal year ending Dec. 31, 2026, but the previous year’s audit will remain with Grant Thornton. This shift probably isn’t behind Tuesday’s market moves, but investors tend to watch these changes closely, looking for clues about timing and oversight.

Traders now focus on whether the Husky refinancing deals set to wrap up on Jan. 14 go through smoothly. They’re also eyeing CompoSecure’s planned rebrand and its ticker change to GPGI at the open on Jan. 23, hoping for a seamless transition.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Seadrill Limited stock jumps 7% as oil rally blunts Citi downgrade
Previous Story

Seadrill Limited stock jumps 7% as oil rally blunts Citi downgrade

XRP price ticks up as U.S. Senate crypto rules bill lands; traders eye Jan. 15 markup
Next Story

XRP price ticks up as U.S. Senate crypto rules bill lands; traders eye Jan. 15 markup

Go toTop